Cycles de traitement par médicament de substitution aux opiacés dans une cohorte de patients suivis 5 ans en médecine ambulatoire
Therapie, 68 3 (2013) 155-161
Published online: 2013-07-26
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Impact of urine drug screening on opioid agonist treatment maintenance with buprenorphine in primary care in France: A cluster-randomized trial
Julie Dupouy, Vanessa Rousseau, Nicolas Authier, Paolo Di Patrizio, Gaetan Gentile, Valérie Gibaja, Catherine Laporte, Laurent Letrilliart, Christine Maynié, Joëlle Micallef, Michel Mallaret, Stéphane Oustric, Emilie Bérard and Maryse Lapeyre-MestreTherapies (2025)
https://doi.org/10.1016/j.therap.2025.07.003
GPs’ practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network
Barbara Lépine, Marion Debin, Lise Dassieu, Laetitia Gimenez, Aurore Palmaro, Camille Ponté, Morgane Swital, Maryse Lapeyre-Mestre, Thierry Blanchon and Julie DupouyTherapies 79 (6) 646 (2024)
https://doi.org/10.1016/j.therap.2024.04.002
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
Louisa Degenhardt, Brodie Clark, Georgina Macpherson, Oscar Leppan, Suzanne Nielsen, Emma Zahra, Briony Larance, Jo Kimber, Daniel Martino-Burke, Matthew Hickman and Michael FarrellThe Lancet Psychiatry 10 (6) 386 (2023)
https://doi.org/10.1016/S2215-0366(23)00095-0
Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution
Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-MestreTherapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078
Améliorer la balance bénéfices/risques de la méthadone en respectant ses spécificités pharmacologiques
Elisabeth Frauger, Nathalie Fouilhé Sam-Laï, Michel Mallaret and Joëlle MicallefTherapies 74 (3) 383 (2019)
https://doi.org/10.1016/j.therap.2018.09.070
Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder
Natalia Shcherbakova, Gary Tereso, Jacqueline Spain and Robert J. RooseAnnals of Pharmacotherapy 52 (5) 405 (2018)
https://doi.org/10.1177/1060028017751913
Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France
A. Cousien, V. C. Tran, S. Deuffic‐Burban, M. Jauffret‐Roustide, G. Mabileau, J.‐S. Dhersin and Y. YazdanpanahJournal of Viral Hepatitis 25 (10) 1197 (2018)
https://doi.org/10.1111/jvh.12919
Caractéristiques des sujets sous traitement de substitution vus en médecine générale d’après l’enquête nationale OPEMA 2013
Gaëtan Gentile, Elisabeth Frauger, Adeline Giocanti, et al.Therapies 71 (3) 307 (2016)
https://doi.org/10.1016/j.therap.2016.02.001
Use of a multi‐state model in a claims database: illustration with methadone
Quentin Boucherie, Vanessa Pauly, Elisabeth Frauger, Xavier Thirion, Vincent Pradel and Joëlle MicallefPharmacoepidemiology and Drug Safety 24 (9) 991 (2015)
https://doi.org/10.1002/pds.3835